logo
Strides Pharma Science Ltd.
11 Nov 2025, 12:00AM
882.55
-0.63%
Geojit BNP Paribas
Management remains optimistic about performance in other regulated markets, anticipating stronger revenue growth in FY26 as European partners prepare for product launches. The company also expects these markets to eventually generate...
Strides Pharma Scien.. has an average target of 1085.00 from 1 broker.
More from Strides Pharma Science Ltd.
Recommended